ReviewNon-coding RNA research2026
Transfer RNA-derived small RNAs in cardiovascular diseases: Progress and perspectives.
Review in Non-coding RNA research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
tRNA-derived small RNAs (tsRNAs) are a class of noncoding RNAs (ncRNAs) generated via the site-specific enzymatic cleavage of mature or precursor tRNAs. They are ubiquitously expressed across diverse species and are detectable in numerous cell lineages and extracellular fluids like blood and serum. They regulate gene expression at multiple levels and are functionally implicated in pivotal biological processes, including cell cycle regulation and immune response modulation. Accumulating evidence has implicated tsRNAs in both the initiation and development of cardiovascular diseases (CVDs). This article provides an overview of the classification and biological functions of tsRNAs before delving into their specific roles and mechanisms in cardiovascular pathophysiology. It aims to offer perspectives on novel therapeutic strategies, as well as the early diagnosis and prognosis assessment of CVDs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.